Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer

被引：4
|
作者：
Sha, Huanhuan [1 ]
Gan, Yujie [1 ]
Zou, Renrui [1 ]
Wu, Jianzhong [2 ]
Feng, Jifeng [1 ]
机构：
[1] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Chemotherapy,Affiliated Canc Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Res Ctr Clin Oncol,Affiliated Canc Hosp, Nanjing, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
PARPs; ADP-ribosylation; cancer; mechanism; biological process; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; B-CELL LYMPHOMAS; BREAST-CANCER; POLY(ADP-RIBOSE) POLYMERASES; COLORECTAL-CANCER; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; OVARIAN-CANCER; PARP6; ACTS;
D O I：
10.3389/fonc.2021.790967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Poly ADP ribose polymerases (PARPs) catalyze the modification of acceptor proteins, DNA, or RNA with ADP-ribose, which plays an important role in maintaining genomic stability and regulating signaling pathways. The rapid development of PARP1/2 inhibitors for the treatment of ovarian and breast cancers has advanced research on other PARP family members for the treatment of cancer. This paper reviews the role of PARP family members (except PARP1/2 and tankyrases) in cancer and the underlying regulatory mechanisms, which will establish a molecular basis for the clinical application of PARPs in the future.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer
    Li, Da
    Bi, Fang-Fang
    Chen, Na-Na
    Cao, Ji-Min
    Sun, Wu-Ping
    Zhou, Yi-Ming
    Li, Chun-Yan
    Yang, Qing
    CELL CYCLE, 2014, 13 (21) : 3442 - 3449
  • [42] The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair
    Herrmann, Geoffrey K.
    Yin, Y. Whitney
    BIOMOLECULES, 2023, 13 (08)
  • [43] Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
    Kulkarni, Sanat
    Gajjar, Ketankumar
    Madhusudan, Srinivasan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer
    Garber, Haven R.
    Litton, Jennifer K.
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 247 - 255
  • [45] DNA Repair Enzymes Promising in Cancer Therapy; Poly (ADP-Ribose) Polymerase Inhibitors
    Demir, Zehra
    Karahalil, Bensu
    GAZI MEDICAL JOURNAL, 2022, 33 (03): : 312 - 321
  • [46] Integrated, Integral, and Exploratory Biomarkers in the Development of Poly(ADP-Ribose) Polymerase Inhibitors
    Konecny, Gottfried E.
    Chander, Cinthiya
    Zhang, Liying
    CANCER JOURNAL, 2021, 27 (06): : 482 - 490
  • [47] BMN-673 Poly [ADP-ribose] Polymerase (PARP) Inhibitor Oncolytic
    Gras, Jordi
    DRUGS OF THE FUTURE, 2013, 38 (12) : 813 - 819
  • [48] Poly(ADP-Ribose) Polymerase Inhibitors A Novel Drug Class With a Promising Future
    Gartner, Elaina M.
    Burger, Angelika M.
    LoRusso, Patricia M.
    CANCER JOURNAL, 2010, 16 (02): : 83 - 90
  • [49] Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research
    Washington, Christina
    Gunderson, Camille C.
    Moore, Kathleen N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (01) : 4 - 11
  • [50] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Banasik, Marek
    Stedeford, Todd
    Strosznajder, Robert P.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 55 - 63
12345